Regulation of GLUT4 biogenesis in muscle: evidence for involvement of AMPK and Ca(2+)

Am J Physiol Endocrinol Metab. 2002 May;282(5):E1008-13. doi: 10.1152/ajpendo.00512.2001.

Abstract

There is evidence suggesting that adaptive increases in GLUT4 and mitochondria in skeletal muscle occur in parallel. It has been reported that raising cytosolic Ca(2+) in myocytes induces increases in mitochondrial enzymes. In this study, we tested the hypothesis that an increase in cytosolic Ca(2+) induces an increase in GLUT4. We found that raising cytosolic Ca(2+) by exposing L6 myotubes to 5 mM caffeine for 3 h/day for 5 days induced increases in GLUT4 protein and in myocyte enhancer factor (MEF)2A and MEF2D, which are transcription factors involved in regulating GLUT4 expression. The caffeine-induced increases in GLUT4 and MEF2A and MEF2D were partially blocked by dantrolene, an inhibitor of sarcoplasmic reticulum Ca(2+) release, and completely blocked by KN93, an inhibitor of Ca(2+)-calmodulin-dependent protein kinase (CAMK). Caffeine also induced increases in MEF2A, MEF2D, and GLUT4 in rat epitrochlearis muscles incubated with caffeine in culture medium. 5-Aminoimidazole-4-carboxamide ribonucleoside (AICAR), which activates AMP-activated protein kinase (AMPK), also induced approximately twofold increases in GLUT4, MEF2A, and MEF2D in L6 myocytes. Our results provide evidence that increases in cytosolic Ca(2+) and activation of AMPK, both of which occur in exercising muscle, increase GLUT4 protein in myocytes and skeletal muscle. The data suggest that this effect of Ca(2+) is mediated by activation of CAMK and indicate that MEF2A and MEF2D are involved in this adaptive response.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • AMP-Activated Protein Kinase Kinases
  • Aminoimidazole Carboxamide / analogs & derivatives*
  • Aminoimidazole Carboxamide / pharmacology
  • Animals
  • Caffeine / pharmacology
  • Calcium / metabolism*
  • Calcium-Calmodulin-Dependent Protein Kinases / metabolism
  • Cells, Cultured
  • Cytosol / metabolism
  • DNA-Binding Proteins / metabolism
  • Glucose Transporter Type 1
  • Glucose Transporter Type 3
  • Glucose Transporter Type 4
  • Hypoglycemic Agents / pharmacology
  • MEF2 Transcription Factors
  • Male
  • Monosaccharide Transport Proteins / biosynthesis*
  • Monosaccharide Transport Proteins / metabolism
  • Muscle Fibers, Skeletal / cytology
  • Muscle Fibers, Skeletal / drug effects
  • Muscle Fibers, Skeletal / enzymology
  • Muscle Proteins*
  • Muscle, Skeletal / cytology
  • Muscle, Skeletal / enzymology*
  • Myogenic Regulatory Factors
  • Nerve Tissue Proteins*
  • Phosphodiesterase Inhibitors / pharmacology
  • Protein Kinases / metabolism*
  • Rats
  • Rats, Wistar
  • Ribonucleotides / pharmacology
  • Transcription Factors / metabolism

Substances

  • DNA-Binding Proteins
  • Glucose Transporter Type 1
  • Glucose Transporter Type 3
  • Glucose Transporter Type 4
  • Hypoglycemic Agents
  • MEF2 Transcription Factors
  • Monosaccharide Transport Proteins
  • Muscle Proteins
  • Myogenic Regulatory Factors
  • Nerve Tissue Proteins
  • Phosphodiesterase Inhibitors
  • Ribonucleotides
  • Slc2a3 protein, rat
  • Slc2a4 protein, rat
  • Transcription Factors
  • Aminoimidazole Carboxamide
  • Caffeine
  • Protein Kinases
  • Calcium-Calmodulin-Dependent Protein Kinases
  • AMP-Activated Protein Kinase Kinases
  • AICA ribonucleotide
  • Calcium